You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Baxter
Boehringer Ingelheim
McKesson
Johnson and Johnson

Last Updated: April 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Teva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Teva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)

Docket   Start Trial Date Filed 2014-09-10
Court District Court, D. Delaware Date Terminated 2017-01-31
Cause 35:271 Patent Infringement Assigned To Colm Felix Connolly
Jury Demand Defendant Referred To
Parties AMNEAL PHARMACEUTICALS COMPANY GMBH; AMNEAL PHARMACEUTICALS LLC; DR REDDY'S LABORATORIES INC.; DR REDDY'S LABORATORIES LTD; MOMENTA PHARMACEUTICALS INC.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; NATCO PHARMA LTD.; PFIZER INC.; SANDOZ INC.; SYNTHON B.V.; SYNTHON PHARMACEUTICALS INC.; SYNTHON S.R.O. BLANSKO; TEVA NEUROSCIENCE INC; TEVA PHARMACEUTICAL INDUSTRIES LTD; TEVA PHARMACEUTICALS USA INC.; YEDA RESEARCH AND DEVELOPMENT CO LTD.
Patents 5,508,020; 5,585,007; 5,641,803; 5,703,017; 5,708,011; 6,054,430; 6,342,476; 6,362,161; 6,468,967; 6,483,009; 6,509,013; 6,852,689; 7,199,098; 7,511,014; 8,232,250; 8,367,605; 8,399,413; 8,552,025; 8,642,025; 8,969,302; 9,155,776; 9,533,022; 9,555,023
Attorneys Aaron M. Nelson; Alfred Henry Heckel; Alison Haddock Hutton; Anthony J. Fitzpatrick; Arun John Mohan; Beshoy Sharoupim; Brandon M. White; Brian J. Prew; Brian J. Robinson; Brian M. Kramer; Carolyn A. Alenci; Christopher P. Galligan; Christopher S. Kroon; Constance S. Huttner; Courtney M. Prochnow; Crystal R. Canterbury; Daniel P. Margolis; Daryl L. Wiesen; David A. Bilson; David J. Austin; David L. Anstaett; David M. Fry; David M. Hashmall; Deanne M. Mazzochi; Dominick T. Gattuso; E. Anthony Figg; Elizabeth J. Holland; Emily J. Greb; Erin M. Forbes; Eve H. Ormerod; Frederick L. Cottrell , III; Grant J. Esposito; Jennifer P. Nock; John C. Phillips , Jr.; John T. Bennett; John W. Shaw; Karen Elizabeth Keller; Marta Godecki; Matthew I. Kreeger; Matthew V. Anderson; Melanie K. Sharp; Nathan Roger Hoeschen; Neal C. Belgam; Nicholas K. Mitrokostas; Patrick C. Gallagher; Rachel Krevans; Rachel L. Pernic Waldron; Randy Elizabeth Brenner-Leifer; Richard D. Kirk; Richard L. Renck; Robert D. Swanson; Robert M. Vrana; Sara E. Bussiere; Selena E. Molina; Seth E. Cockrum; Shannon M. Bloodworth; Sharon L. Davis; Stephen B. Brauerman; Thomas H. Ehrich; Vanessa Ribeiro Tiradentes; Vincent L. Capuano; William A. Rakoczy; William G. James
Firms Bayard, P.A.; Duane Morris, LLP; Gould & Ratner LLP; Heyman Enerio Gattuso & Hirzel LLP; Law Office of Michael R. Abram; Phillips, Goldman, McLaughlin & Hall, P.A.; Richards, Layton & Finger, PA; Selena E. Molina; Shaw Keller LLP; Smith, Katzenstein, & Jenkins LLP; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Teva Pharmaceuticals USA Inc. v. Sandoz Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Teva Pharmaceuticals USA Inc. v. Sandoz Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Teva Pharmaceuticals USA Inc. v. Sandoz Inc. (D. Del. 2014)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 Complaint entN o. 8 ,232,250 (“t h e’250pa t ent …2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. External link to document
0000-00-00 114 Stipulation invalidity of U.S. Patent Nos. 8,232,250 (“the ’250 patent”), 8,399,413 (“the ’413 patent”), and 8,969,3028,969,302 (“the ’302 patent) (collectively, the “patents-in-suit”), which, like the ’776 patent, are …’776 patent shares a common inventor and specification with the patents-in-suit and each patent is generally… Court: WHEREAS, U.S. Patent No. 9,155,776 (“the ’776 patent”) issued on October 13, 2015 and…that the patents involve similar subject matter, amending the pleadings to include the ’776 patent would External link to document
0000-00-00 116 Patent/Trademark Report to Commissioner the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,232,250; 8,399,413; 8,969,302…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. External link to document
0000-00-00 127 Notice of Service Defendants' Proposed Claim Constructions for U.S. Patent No. 9,155,776 filed by Mylan Inc., Mylan Pharmaceuticals…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. External link to document
0000-00-00 130 Notice of Service Joint Invalidity Contentions Regarding U.S. Patent No. 9,155,776 B2 filed by Momenta Pharmaceuticals Inc.…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. External link to document
0000-00-00 139 Claim Construction Opening Brief CONSTRUCTION OPENING BRIEF Regarding U.S. Patent No. 9,155,776 filed by Momenta Pharmaceuticals Inc., Sandoz…2014 31 January 2017 1:14-cv-01171 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
McKesson
Moodys
Harvard Business School
Medtronic
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.